3645 results for «569»
3645 results
The value of intravascular imaging in the planning - Optimisation of PCI and dealing with complications
20 May 2026 – From EuroPCR 2026
Highlighting the critical role of intravascular imaging in PCI, this session explores its utility in procedural planning, optimization of outcomes, and identification and management of complications. Through international case studies, it demonstrates how imaging enhances understanding beyond angiography alone and facilitates tailored, effective interventions.
Unconventional situations during cardiovascular interventions
20 May 2026 – From EuroPCR 2026
This session addresses unconventional and challenging scenarios encountered during cardiovascular interventions, focusing on managing complications effectively in the cathlab. Through detailed case presentations from Argentina, Chile, and Colombia, it explores innovative approaches to acute aortic valve regurgitation, TAVI complications in bicuspid anatomy, and diagnostic dilemmas in...
To rescue the unexpected complications during TAVI
20 May 2026 – From EuroPCR 2026
This session focuses on the recognition and management of unexpected complications during TAVI procedures. Through cases from Hong Kong, Kazakhstan, and Uzbekistan, it examines mechanisms underlying common and rare complications such as aortic sinus injury, acute valve dislocation, and left main collapse. Attendees gain practical insights...
Lessons from the long-term DES data: how they can inform today's practice
20 May 2026 – From EuroPCR 2026
This session reviews long-term clinical data on drug-eluting stents (DES) and bioresorbable scaffolds (BRS), offering valuable insights to inform current interventional cardiology practice. It covers seven-year outcomes of magnesium scaffolds in ACS, five-year results of sirolimus-eluting iron BRS, and extensive post-market studies of various thin-strut and...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
